Loxo Oncology to Present at Upcoming Investor Conferences
Aug 30, 2017 10:45 am UTC| Business
STAMFORD, Conn., Aug. 30, 2017 -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced...
Epizyme to Participate in Upcoming Investor Conferences
Aug 30, 2017 10:30 am UTC| Business
CAMBRIDGE, Mass., Aug. 30, 2017 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will participate in the following...
Prima BioMed and Monash University Receive Funding Grant for LAG-3 Research Project
Aug 30, 2017 10:07 am UTC| Business
SYDNEY, Australia, Aug. 30, 2017 -- Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima” or the “Company”) announces that the Australian Research Council (ARC) has awarded Prima and research partner Monash University a...
Digitalization Among Factors Pushing Millennial Credit Preferences Toward Auto and Personal Loans
Aug 30, 2017 10:03 am UTC| Business
CHICAGO, Aug. 30, 2017 -- As the first generation to be fully immersed in mass-market digitalization, Millennials are slowing their credit card usage while increasingly using other credit products such as personal...
Camber Energy Announces Receipt of Notice of Non-Compliance From NYSE American
Aug 30, 2017 10:01 am UTC| Business
SAN ANTONIO, Aug. 30, 2017 -- Camber Energy, Inc. (NYSE American:CEI) (“Camber” or the “Company”), an independent oil and gas company, announces that on August 22, 2017, it was notified by the NYSE American (the...
Xehar Uses Data to Put the Smart in their Smart Phone App
Aug 30, 2017 10:00 am UTC| Business
Focusing on data analytics and strategic partnerships, the Xehar App looks to create a seamless shopping experience for users by connecting to other social apps and shopping platforms. ...
Isodiol International Inc. Announces Distribution Agreement for South America
Aug 30, 2017 10:00 am UTC| Business
VANCOUVER, British Columbia, Aug. 30, 2017 -- Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (FSE:LB6A.F) (the “Company” or “Isodiol”) a global cannabinoid innovator specializing in the development of pharmaceutical...